PE/TR Anti-Human CD44 Antibody[P2A1]

Introducing the PE/TR Anti-Human CD44 Antibody [P2A1], a highly advanced and meticulously developed product designed to cater to the needs of the scientific community. This antibody, meticulously crafted with utmost precision, offers unparalleled specificity and sensitivity in detecting the CD44 antigen in human samples.

The PE/TR Anti-Human CD44 Antibody [P2A1] is a cutting-edge tool that enables researchers to delve into the intricate world of CD44 expression and its role in various biological processes. With its exceptional performance, this antibody empowers scientists to unravel the mysteries surrounding CD44, a cell surface glycoprotein involved in cell adhesion, migration, and signaling.

Crafted with the utmost care, this antibody exhibits remarkable binding affinity and selectivity towards the CD44 antigen, ensuring accurate and reliable results. Its dual labeling with PE and TR fluorochromes allows for simultaneous detection and analysis of CD44 expression, facilitating a comprehensive understanding of its distribution and dynamics within the sample.

The PE/TR Anti-Human CD44 Antibody [P2A1] is meticulously validated through rigorous quality control measures, guaranteeing consistent and reproducible outcomes. Its exceptional performance is further enhanced by its compatibility with various experimental techniques, including flow cytometry and immunofluorescence, enabling seamless integration into diverse research workflows.

With its exceptional specificity, sensitivity, and versatility, the PE/TR Anti-Human CD44 Antibody [P2A1] is an indispensable tool for researchers aiming to unravel the complexities of CD44 biology. Whether investigating its involvement in cancer progression, stem cell biology, or immune response, this antibody empowers scientists to unlock new insights and advance scientific knowledge.

Choose the PE/TR Anti-Human CD44 Antibody [P2A1] for its unparalleled performance, reliability, and compatibility with a wide range of applications. Elevate your research endeavors and embark on a journey of discovery with this exceptional antibody, designed to revolutionize the field of CD44 research.